212 related articles for article (PubMed ID: 12424963)
1. [A patient with Parkinson's disease complicated by hypothyroidism who developed malignant syndrome after discontinuation of etizolam].
Kawajiri M; Ohyagi Y; Furuya H; Araki T; Inoue N; Esaki S; Yamada T; Kira J
Rinsho Shinkeigaku; 2002 Feb; 42(2):136-9. PubMed ID: 12424963
[TBL] [Abstract][Full Text] [Related]
2. [A successfully treated parkinsonian patient with neuroleptic malignant syndrome complicated by status epilepticus and disseminated intravascular coagulation].
Osoegawa M; Motomura S; Yamanaka H; Tamura K; Miyoshi T
Rinsho Shinkeigaku; 1999 Jun; 39(6):653-7. PubMed ID: 10502992
[TBL] [Abstract][Full Text] [Related]
3. [Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) with disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease].
Yamawaki Y; Ogawa N
Rinsho Shinkeigaku; 1991 Jan; 31(1):62-7. PubMed ID: 2044308
[TBL] [Abstract][Full Text] [Related]
4. [Diazepam-responsive malignant catatonia in a patient with an initial clinical diagnosis of neuroleptic malignant syndrome: a case report].
Mishima T; Tsuboi Y; Higuchi MA; Tsugawa J; Obata T; Yamada T
Brain Nerve; 2011 May; 63(5):503-7. PubMed ID: 21515931
[TBL] [Abstract][Full Text] [Related]
5. [Neuroleptic malignant syndrome after cardiac surgery].
Uehara M; Inaoka M; Miyaki Y; Nakashima S; Fuzii A; Higami T
Kyobu Geka; 2013 Nov; 66(12):1052-5. PubMed ID: 24322311
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic malignant syndrome with delayed onset of fever following risperidone administration.
Norris B; Angeles V; Eisenstein R; Seale JP
Ann Pharmacother; 2006 Dec; 40(12):2260-4. PubMed ID: 17119106
[TBL] [Abstract][Full Text] [Related]
7. A case of malignant syndrome associated with a parkinsonism patient.
Sanga M; Nomura S
Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Apr; 23(2):91-5. PubMed ID: 12762221
[TBL] [Abstract][Full Text] [Related]
8. [Neuroleptic malignant syndrome associated with the syndrome of inappropriate secretion of antidiuretic hormone].
Yamaguchi K; Takamoto K; Yagi K; Tanabe H
Rinsho Shinkeigaku; 1995 Feb; 35(2):180-3. PubMed ID: 7781236
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of neuroleptic malignant syndrome.
Guerrero RM; Shifrar KA
Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662
[TBL] [Abstract][Full Text] [Related]
10. Possible neuroleptic malignant syndrome related to concomitant treatment with paroxetine and alprazolam.
Tanii H; Ichihashi K; Inoue K; Fujita K; Okazaki Y
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1176-8. PubMed ID: 16720068
[TBL] [Abstract][Full Text] [Related]
11. [A case of Satoyoshi syndrome with symptoms resembling neuroleptic malignant syndrome].
Adachi H; Riku S; Fujishiro K; Kuru S
Rinsho Shinkeigaku; 1998 Jul; 38(7):637-40. PubMed ID: 9868307
[TBL] [Abstract][Full Text] [Related]
12. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
Borovicka MC; Bond LC; Gaughan KM
Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
[TBL] [Abstract][Full Text] [Related]
13. [Increase in serum creatine phosphokinase following administration of talipexole hydrochloride].
Osumi E; Imai T
Rinsho Shinkeigaku; 2000 Oct; 40(10):1041-3. PubMed ID: 11296371
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic malignant syndrome: a review and report of six cases.
Kasantikul D; Kanchanatawan B
J Med Assoc Thai; 2006 Dec; 89(12):2155-60. PubMed ID: 17214072
[TBL] [Abstract][Full Text] [Related]
15. [Neuroleptic malignant syndrome after aortic valve replacement; report of a case].
Ichiba T; Takemoto N
Kyobu Geka; 2003 Sep; 56(10):872-4. PubMed ID: 13677924
[TBL] [Abstract][Full Text] [Related]
16. [The malignant neuroleptic syndrome and malignant hyperthermia].
Mitterschiffthaler G; Hackl JM; Neumann R
Anaesthesist; 1989 Apr; 38(4):210-3. PubMed ID: 2729540
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) and disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease.
Yamawaki Y; Ogawa N
Intern Med; 1992 Nov; 31(11):1298-302. PubMed ID: 1295627
[TBL] [Abstract][Full Text] [Related]
18. Possible malignant neuroleptic syndrome that associated with hypothyroidism.
Taskapan C; Sahin I; Taskapan H; Kaya B; Kosar F
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):745-8. PubMed ID: 15927337
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study.
Ward C
J Neurosci Nurs; 2005 Jun; 37(3):160-2. PubMed ID: 16001822
[TBL] [Abstract][Full Text] [Related]
20. [Neuroleptic malignant syndrome in a patient with polyneuropathy: mechanism of muscle rigidity and elevated serum creatine kinase levels].
Takashima S; Hirade S; Taguchi Y; Inoue H
Rinsho Shinkeigaku; 1998; 38(10-11):955-7. PubMed ID: 10203983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
